• 26 August, 2025

Alniche Lifesciences forays into cardio-diabetic area

September 29, 2021 | Wednesday | News

Introduction of value-added products to take care of vital organs of circulatory system

Image Credit: Shutterstock

Image Credit: Shutterstock

Alniche Lifesciences is planning to expand into a new therapy area i.e. cardio-diabetic. This includes the introduction of value-added products to take care of vital organs of the circulatory system that is severely affected due to the COVID-19 pandemic.  

 

Girish Arora, Founder & MD - Alniche Lifesciences said, "The company intends to broaden its reach through exports, since Indian pharmaceutical products possess a high reputation in other countries, putting India among the top five pharmaceutical exporters in the world.’’

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up
New User? Create Account

Trending Topics

Most Read

Survey Box

Can Policy Reforms & Investments Trigger India’s MedTech Makeover?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy